Kane Biotech (KNE) Cash flow

1 Followers

Kane Biotech Cash Flow

TSE:KNE's free cash flow for Q4 2025 was C$-591.01K. For the 2025 fiscal year, TSE:KNE's free cash flow was decreased by C$875.78K and operating cash flow was C$-680.61K. See a summary of the company’s cash flow.

Cash Flow	Dec 25	Mar 25	Dec 23	Mar 23	Dec 21
Operating Cash Flow	C$ -3.26M	C$ -4.11M	C$ -3.22M	C$ -3.04M	C$ -2.29M
Investing Cash Flow	C$ -53.13K	C$ 10.27M	C$ -116.14K	C$ -107.55K	C$ -373.55K
Financing Cash Flow	C$ 3.85M	C$ -7.69M	C$ 2.98M	C$ 3.10M	C$ 2.81M
End Cash Position	C$ 901.70K	C$ 358.81K	C$ 749.25K	C$ 1.10M	C$ 1.15M
Free Cash Flow	C$ -3.26M	C$ -4.14M	C$ -3.23M	C$ -3.13M	C$ -2.64M

Currency in CAD